China eyed for pharmaceutical export

Published: 2010-04-06 07:00:00

Updated: 2010-04-06 07:00:00

China has been one of the attractive markets for Korea drugmakers, but its strict regulatory drug filing has so far been a stumbling block.

The Korea Pharmaceutical Manufacturers Association (KPMA) hopes that a Memorandum of Understanding (MOU) signed on March 31 with the China Pharmaceutical ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK